Clinical trial
A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetics of Subcutaneous JS005 in Chinese Adults With Active Non-radiographic Axial Spondyloarthritis
NCT05242588 is registered in ClinicalTrials.gov with Shanghai Junshi Bioscience Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetics of Subcutaneous JS005 in Chinese Adults With Active Non-radiographic Axial Spondyloarthritis
- Lead sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2021
- Completion date
- June 30, 2023
- Enrollment
- 23 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.